Genetic ablation of IKK-β/NF-κB signaling in neurons by impairing IKK-β activity is sufficient to reduce food intake, body weight gain, and glucose intolerance typically observed in high fat diets, thus highlighting this pathway as a promising therapeutic target [10,14,16]. This evidence concerns the gene IKBKB and Glucose intolerance.